Picture of Sinopharm Co logo

SHTDF Sinopharm Co Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Momentum

Relative Strength (%)
1m+1.79%
3m+2.74%
6m-14.21%
1yr-25.8%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-23.97%
50d MA+7.94%
200d MA+7.3%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)6.27
PEG Ratio (f)0.55
EPS Growth (f)13.01%
Dividend Yield (f)4.73%
Valuation (ttm)IndustryMarket
Price to Book Value0.86
Price to Tang. Book1
Price to Free Cashflow6.22
Price to Sales0.1
EV to EBITDA6.04

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital15.44%
Return on Equity13.45%
Operating Margin3.56%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueCNYm344,525.82425,272.73456,414.61521,051.23552,147.55608,372.84667,786.3512.36%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+13.57+3.99+9.38+12.29+4.47+2.79+13.01n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Sinopharm Co EPS forecast chart

Profile Summary

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
January 8th, 2003
Public Since
September 23rd, 2009
No. of Employees
113,362
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
3,120,656,000

SHTDF Share Price Performance

Upcoming Events for SHTDF

Q1 2024 Sinopharm Group Co Ltd Earnings Release

Dividend For 1099.HK - 0.8700 CNY

Sinopharm Group Co Ltd Annual Shareholders Meeting

Half Year 2024 Sinopharm Group Co Ltd Earnings Release

Similar to SHTDF

Picture of Acacia Diversified Holdings logo

Acacia Diversified Holdings

us flag iconPink Sheets on Nasdaq

Picture of Acusphere logo

Acusphere

us flag iconPink Sheets on Nasdaq

Picture of Adorbs logo

Adorbs

us flag iconPink Sheets on Nasdaq

Picture of Agentix logo

Agentix

us flag iconPink Sheets on Nasdaq

Picture of Agrios Global Holdings logo

Agrios Global Holdings

us flag iconPink Sheets on Nasdaq

FAQ